Average Co-Inventor Count = 3.53
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gen1e Lifesciences Inc. (8 from 8 patents)
2. Exelixis, Inc. (2 from 172 patents)
3. Genie Lifesciences Inc. (2 from 2 patents)
4. University System of Maryland (1 from 1,910 patents)
12 patents:
1. 12404259 - Inhibitors of extracellular signal-regulated kinase
2. 12331024 - Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors
3. 12269792 - Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate
4. 12116353 - Crystalline chloro-n-(4-(morpholinomethyl)phenyl)benzamide and crystalline hydrochloride salt
5. 11976049 - Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors
6. 11926635 - P38α mitogen-activated protein kinase inhibitors
7. 11555020 - Substituted naphthyl p38α mitogen-activated protein kinase inhibitors
8. 11440918 - p38α mitogen-activated protein kinase inhibitors
9. 11390581 - Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate
10. 11286260 - P38α mitogen-activated protein kinase inhibitors
11. 8440663 - 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use
12. 8088767 - JAK-2 modulators and methods of use